Sleep Disturbance as a Non-Traditional Risk Factor in CKD

Conditions:		Chronic Kidney Disease
Purpose:		This study is designed to determine if either short night time sleep or poor night time sleep could be a risk factor for increasing the rate at which kidney function deteriorates in persons with mild to moderate kidney disease.
Study Summary:
Criteria:		Inclusion Criteria: - Mild to Moderate CKD - Healthy controls age and gender matched to CKD subjects - Regular bedtimes of at least 6h/night, sedentary lifestyle Exclusion Criteria: - Diabetes - Current or previous dialysis for more than 1 month - Uncontrolled hypertension - Heart failure - Liver disease - HIV - Hemoglobin < 10.5 g/dl - Treatment with EProcrit, Epogen, or Aranesp - Bone or organ transplant, - Use of immunosuppressive drugs within past 6 months - Current oral contraceptive use - Current pregnancy - Chemotherapy for malignancy within past 2 years
NCT ID:		NCT00817427
Primary Contact:		Principal Investigator Eve Van Cauter, PhD University of Chicago Annette Miller, RN, MSN Phone: 773-834-8871 Email: amiller@medicine.bsd.uchicago.edu
Backup Contact:		N/A
Location Contact:		Chicago, Illinois 60637 United States *There is no listed contact information for this specific location.* Site Status: Recruiting

Data Source:		ClinicalTrials.gov
Date Processed:		May 22, 2013
Modifications to this listing:		Only selected fields are shown, please use the link below to view all information about this clinical trial.
Click to view Full Listing


If you would like to be contacted by the clinical trial representative please enter your contact information, then click "I Am Interested In This Study"

First Name:

Last Name:

Email Address:

Confirm Email:

Daytime Phone (eg. 555-555-5555):

City:

State:

Zip Code:

Best Time to Call:

Morning	Afternoon	Evening
Please contact me by email instead of calling.

Questions/Comments:

I have read and agree with the Privacy Policy

I have reviewed the eligibility criteria and believe I am eligible for this clinical trial

I would like to be notified about new clinical trials.